HIV/AIDS Therapy
Topical microbicide prevents and/or treats oculo-genital adenovirus/HIV infections
Published in Immunotherapy Weekly, January 4th, 2006
"Adenoviruses (ADVs) are causative agents of severe and extremely contagious ocular and genital infections associated with conjunctivitis, genital ulcers and urethritis. Yet no functional antiviral compounds are currently available against adenoviral infections," investigators in the United States report.
According to O.J. Dcruz and colleagues at Parker Hughes Institute in St. Paul, "We discovered halogen-substituted phenyl phosphoramidate derivatives of stavudine (STV/d4T) as a new class of dual-function anti-human immunodeficiency virus (HIV) agents...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-01-04)
More Articles from Immunotherapy Weekly
- Allergy & Immunology
Anti-CD23 agents such as Lumiliximab hold promise as a potential therapy for allergic diseases - Asthma
Vascular endothelial growth factor governs activity in the bronchial passages of asthmatic patients - Immunology
Langerhans cells reported to inhibit immune responses in the skin - Immunology
TRAF3 protein may be a key to early immune response to viruses - Rheumatology
Vascular related molecules signal active rheumatoid arthritis - Adenovirus Vector
Oncolytic adenovirus replicates selectively in tumors - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
